LEAF-4L6715 for respiratory distress syndrome

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 Oct 2024: Trial registered, NCT06640777

The trials

NCT06640777: Efficacy and Safety of LEAF-4L6715 for Acute Respiratory Distress Syndrome

State
Not started
Phase
Phase 3
People
310 planned
Started
1 Nov 2024
Primary completion
9 Nov 2026
Arms
LEAF-4L6715 (Liposomal Transcrocetin) + Supportive Care
Results
None posted
  1. 15 Oct 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.